TREATMENT OF FIBROTIC EYE DISORDERS USING AN MMP2 INHIBITOR

摘要

Inhibitors of matrix metalloproteinase 2 are used to treat or prevent a f?brotic disorder of the posterior capsule of the eye, for example posterior capsule opacification (PCO), or of a tissue or structure of the eye other than the lens or capsular bag.